Biology innovation is becoming both more global and more fragmented at the same time. As synthetic biology, AI-driven drug discovery, and biomanufacturing scale worldwide, nations and companies are simultaneously competing for technological leadership while relying on cross-border collaboration to accelerate discovery. Export controls, data governance, regional funding strategies, and national bioeconomy agendas are reshaping how partnerships form, yet science, talent, and innovation networks remain deeply interconnected. This session explores how the global biology ecosystem is evolving beyond traditional geopolitics. Leaders from industry, startups, academia, and investment will examine how collaboration and competition coexist across the US, Europe, China, and emerging innovation hubs.